that many? this serious? SPDR S&P Metals & Mining ETF
XME
Direxion Daily Financial Bull 3X Shares ETF
FAS
Spdr S&P Bank Etf
KBE
4
SPDR S&P Retail ETF
XRT
5
Ultra Financials Proshares
UYG
US Stock MarketDetailed Quotes
CalciMedica (CALC)
- 4.330
- -0.260-5.66%
Close Dec 12 16:00 ET
- 4.330
- 0.0000.00%
Post 16:00 ET
62.39MMarket Cap-2.67P/E (TTM)
4.590High4.260Low61.15KVolume4.520Open4.590Prev Close273.39KTurnover1.10%Turnover RatioLossP/E (Static)14.41MShares4.81552wk High-227.89P/B24.08MFloat Cap1.42052wk Low--Dividend TTM5.56MShs Float530.319Historical High--Div Yield TTM7.19%Range %1.420Historical Low4.470Avg Price1Lot Size
CALC Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CALC Orderflow
Unit: --
CALC Orderflow Trend
IntradayDayWeekMonth
No Data
CalciMedica (CALC) News
Oppenheimer Reaffirms Their Buy Rating on CalciMedica (CALC)
CalciMedica | 10-Q: Q3 2025 Earnings Report
CalciMedica | 8-K: CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
CalciMedica Announces Publication in JCI Preclinical Study of CM5480
CalciMedica 3Q Loss/Shr 52c >CALC
CalciMedica 3Q Research and Development Expenses $3.9M >CALC
CalciMedica (CALC) Stock Forum
$CalciMedica (CALC.US)$
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference
Tuesday, 4th March at 7:00 am
62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo in subset of patients in CARDEA with AKI
LA JOLLA, Calif., March 4, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (N...
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference
Tuesday, 4th March at 7:00 am
62.7% relative reduction in mortality at day 30, which persisted through day 60, for patients treated with Auxora versus placebo in subset of patients in CARDEA with AKI
LA JOLLA, Calif., March 4, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (N...
2
Its Friday with shorter trading time. Sleepy already. Some will run and some will get delayed market reaction.
$Applied Therapeutics (APLT.US)$ Crashed after FDA CRL but will resubmit. Dropped from 10 to 1.3 rebounded to 1.95. SI 16%
$PainReform (PRFX.US)$ Microfloat. Up after hours. SI 20%. 0 shares LTB. CTB 436%. If there is no catalyst, microfloats will be a quick play.✔️
$Blue Ocean Acquisition Corp(Delisted) (BOCN.US)$ Merger ...
$Applied Therapeutics (APLT.US)$ Crashed after FDA CRL but will resubmit. Dropped from 10 to 1.3 rebounded to 1.95. SI 16%
$PainReform (PRFX.US)$ Microfloat. Up after hours. SI 20%. 0 shares LTB. CTB 436%. If there is no catalyst, microfloats will be a quick play.✔️
$Blue Ocean Acquisition Corp(Delisted) (BOCN.US)$ Merger ...
51
13
7
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)